Keywords: ardea, gets, go-ahead, ph, rdea594, uk, trial

Ardea gets go-ahead for Ph I RDEA594 UK trial

Article | 01 September 2008

Print This

The USA's Ardea Biosciences says that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized a Phase I ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in